Jack Meehan
Stock Analyst at Barclays
(3.05)
# 1,265
Out of 5,143 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $269.97 | +7.42% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $138.63 | -9.83% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $400.42 | -28.08% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $12.24 | +169.61% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $153.95 | +111.11% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.08 | +34.94% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $182.16 | -45.65% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $186.74 | -3.61% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $6.06 | +65.02% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $239.05 | -30.56% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $75.11 | -42.75% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $224.03 | -31.26% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $305.22 | +40.88% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $310.40 | +38.53% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $30.56 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $52.11 | -7.89% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,438.11 | -52.72% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $78.62 | -61.84% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $639.45 | -53.08% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $0.94 | +4,172.36% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $269.97
Upside: +7.42%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $138.63
Upside: -9.83%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $400.42
Upside: -28.08%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $12.24
Upside: +169.61%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $153.95
Upside: +111.11%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.08
Upside: +34.94%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $182.16
Upside: -45.65%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $186.74
Upside: -3.61%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $6.06
Upside: +65.02%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $239.05
Upside: -30.56%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $75.11
Upside: -42.75%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $224.03
Upside: -31.26%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $305.22
Upside: +40.88%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $310.40
Upside: +38.53%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $30.56
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $52.11
Upside: -7.89%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,438.11
Upside: -52.72%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $78.62
Upside: -61.84%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $639.45
Upside: -53.08%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $0.94
Upside: +4,172.36%